MedTrace Logo

Drug Resistance Among Asymptomatic Infection

NCT03648411 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 765

Last updated 2020-07-22

No results posted yet for this study

Summary

A cross-sectional study will be conducted in selected 2 sentinel sites for assessment of drug resistance falciparum and vivax among asymptomatic infection in migrant workers in Myanmar.

Conditions

  • Drug Resistant Malaria
  • Asymptomatic Infections
  • Migrant Workers

Interventions

GENETIC

Drug resistance molecular markers

Proportion of the drug resistance molecular markers will be found-out and compared.

Sponsors & Collaborators

  • National Malaria Control Program, Myanmar

    collaborator OTHER_GOV

  • Department of Medical Research, Lower Myanmar

    lead OTHER

Principal Investigators

  • Myat H Nyunt, PhD · Department of Medical Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-12
Primary Completion
2019-12-30
Completion
2020-05-20

Countries

  • Burma

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648411 on ClinicalTrials.gov